Risk Of Developing Liver Cancer After HCV Treatment

Saturday, August 4, 2018

Direct Antiviral Therapy of Hep C May Not Boost Hepatocellular-Carcinoma Risk

Direct Antiviral Therapy of Hep C May Not Boost Hepatocellular-Carcinoma Risk
Treatment of hepatitis C (HCV) with direct-acting antiviral agents does not appear to increase the risk of hepatocellular carcinoma (HCC) in individuals with cirrhosis, researchers from France report.



On This Blog
HCC during and after direct-acting antiviral therapy in patients with hepatitis C
Index of research articles investigating the possible risk of developing liver cancer (hepatocellular carcinoma, or HCC) during and after direct-acting antiviral therapy in patients with hepatitis C.

No comments:

Post a Comment